Revestive 5 mg

Revestive 5 mg is a medicine authorised by Swissmedic under authorisation number 65739. The authorisation holder is Takeda Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 September 2016 and the authorisation is valid without a time limit. ATC code A16AX08 places the medicine in the group Other alimentary tract and metabolism products.

  • Dispensing category B
  • Authorisation number 65739
  • ATC A16AX08
  • Biotechnological medicines
Authorisation data
Authorisation number65739
NameRevestive 5 mg
Full nameRevestive 5 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderTakeda Pharma AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeA16AX08
First authorisation01 September 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Revestive 5 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB01 September 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Durchstechflasche(n)A16AX0804.09.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Revestive 5 mg authorised in Switzerland?

Yes. Revestive 5 mg is authorised by Swissmedic under authorisation number 65739, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Revestive 5 mg have?

Revestive 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Revestive 5 mg?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com